Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA issues Class I recall on insulin syringes due to risk of death
A line of syringes manufactured by Cardinal Health may fail to properly inject insulin when used with needleless IV connectors.
Non-invasive imaging technique may be key to diagnosing sepsis earlier
The methods enable providers to identify signs of sepsis by assessing blood flow throughout the muscles.
Eating more plant-based protein reduces risk of heart disease
“Most of us need to begin shifting our diets toward plant-based proteins,” according to one Harvard researcher.
Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement
It's early for RAVR, but the minimally invasive technique has already started gaining momentum as an alternative to both SAVR and TAVR. We spoke to Vinay Badhwar, MD, one of the world’s leading voices in robotic heart surgery, to learn more.
Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups
As more high-risk patients undergo PCI, what is the best antiplatelet strategy following an initial event-free period of DAPT? Does it change after complex PCI? Researchers aimed to answer these questions, and many others, with new findings published in JAMA Cardiology.

doctor examines patient data on their tablet

Radiologists are more accurate, confident when they know the full story

Providing radiologists with key details about the patient's symptoms can go a long way toward improving the quality of their work.

November 18, 2024

Immediate Past President of the American College of Cardiology (ACC) Hadley Wilson, MD, FACC, executive vice chair of Atrium Health Sanger Heart and Vascular Institute and a clinical professor of medicine at Wake Forest University School of Medicine, details the top late-breaking studies at AHA 2024. #AHA24 #AHA2024

9 key takeaways from AHA 2024 in Chicago

Hadley Wilson, MD, spoke to Cardiovascular Business at the three-day event to discuss key late-breaking studies and trends. Topics included new drug treatments, AI and much more.

November 18, 2024

Redo TAVR: A 26-mm Sapien 3 device (Edwards Lifesciences) implanted within a 29-mm CoreValve device (Medtronic). Image courtesy of EuroIntervention.

Redo TAVR: The impact of implanting balloon-expandable valves in failed self-expanding valves

Researchers took a closer look at the effectiveness of redo TAVR, implanting Sapien 3 valves into a variety of explanted CoreValve and Evolut valves.

November 18, 2024

Edoxaban could limit blood clots, ‘make life easier’ for heart valve surgery patients

The popular DOAC was linked to more bleeding events than warfarin, but fewer reports of intracardiac thrombi and other adverse outcomes. Researchers presented their findings at the AHA's Scientific Sessions 2024 conference in Chicago.

November 18, 2024

Experts develop highly sensitive X-ray detector to minimize radiation dose, cut costs

The hope is that by creating detectors that are more sensitive, less ionizing radiation will be needed to produce diagnostic quality imaging.

November 15, 2024

Surgical devices recalled after 17 serious injuries—FDA warns of possible shortage

Vessel harvesting devices from Getinge have been recalled due to pieces breaking off during medical procedures. In some cases, surgeons were unable to retrieve the broken pieces.

November 15, 2024

Video interview with J.D. Corl, MD, explaining the use of the new E8 and Javelin Shockwave IVL catheters in PAD.

New balloonless IVL catheter offers an alternative to atherectomy in tight lesions, CTOs

J.D. Corl, MD, shared his experience using two new IVL catheters from Shockwave Medical to treat patients with heavily calcified peripheral arteries. He considers both new devices a significant upgrade.

November 15, 2024

Treating younger patients with TAVR increases risk of death

Treating patients younger than 65 with TAVR is associated with certain risks for heart teams to consider. Fortunately, researchers found, care teams appear to be choosing patients wisely.

November 15, 2024

Clinical

FDA issues Class I recall on insulin syringes due to risk of death

Non-invasive imaging technique may be key to diagnosing sepsis earlier

Eating more plant-based protein reduces risk of heart disease

Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement

Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups